PignoneMP, GaynesBN, RushtonJL, . Screening for depression in adults: a summary of the evidence for the Preventive U.S. Services Task Force. Ann Intern Med. 2002;136:765–776.
2.
GilbodyS, SheldonT, WesselyS.Should we screen for depression? BMJ. 2006;332:1027–1030.
3.
KatonWJ, LinEH, Von KorffM, . Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363:2611–2620.
4.
MarcusSC, OlfsonM.National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry. 2010;67:1265–1273.
MitchellAJ, VazeA, RaoS.Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009;374:609–619.
7.
GibbonsRD, HurK, BrownCH, . Benefits from antidepressants: synthesis of 6-week patientlevel outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012;69:572–579.
8.
LichtmanJH, BiggerJTJr, BlumenthalJA, ; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–1775.
